These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1088724)

  • 1. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
    Briantseva EA
    Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Live influenza vaccine].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of vitamin A on some biological properties of type B influenza virus.
    Ioniţă E; Lupulescu E; Constantinescu C; Niculescu IT; Creţescu L
    Arch Roum Pathol Exp Microbiol; 1988; 47(2):115-9. PubMed ID: 3250361
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG.
    Zykov MP; Subbotina TI; Rudenko LG; Kaplin NN
    Acta Virol; 1983 Mar; 27(2):160-7. PubMed ID: 6135335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the reproductive and immunogenic activity of moderately attenuated influenza A/1977-1980 viruses].
    Zhilova GP; Ermolaeva OM; Orlov VA
    Tr Inst Im Pastera; 1982; 58():25-30. PubMed ID: 7187550
    [No Abstract]   [Full Text] [Related]  

  • 13. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of immunization with syngeneic monoclonal anti-idiotype antibody on antibody responses to influenza viruses.
    Schulman JL; Moran TM; Reale M; Beilin Y; Sigal N; Bona CA
    Monogr Allergy; 1987; 22():143-9. PubMed ID: 3501830
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ways to increase the specific activity of anti-influenzal donor gamma-globulin].
    Malafeeva LK; Bundzen NG; Polianskaia NIu; Goriunova VV
    Tr Inst Im Pastera; 1976; 47():140-6. PubMed ID: 80044
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influenza A(H1N1) virus drift; alteration of the influenza vaccine for the 1986/'87 season].
    Masurel N; Beyer WE
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1929-30. PubMed ID: 2430197
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-protection of mice immunized with different influenza A (H2) strains and challenged with viruses of the same HA subtype.
    Govorkova EA; Smirnov YuA
    Acta Virol; 1997 Oct; 41(5):251-7. PubMed ID: 9607078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus].
    Aleksandrova GI
    Vopr Virusol; 1977; (4):387-95. PubMed ID: 335659
    [No Abstract]   [Full Text] [Related]  

  • 20. [Host antigens in purified preparations of the influenza virus].
    Zhebrun AB; Polianskaia NIu; Noskov FS; Fridman EA
    Tr Inst Im Pastera; 1982; 59():70-81. PubMed ID: 7187572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.